Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Holmberg

Showing results (201-210 of 256) with videos related to

Pageof 26
Sort By:
Transfusion|March 4, 2011
The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plansGraham Simmons, Simone A Glynn, Jerry A Holmberg, et al.
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 27, 2018
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance TherapyAndrew J Cowan, Philip A Stevenson, Edward N Libby, et al.
Transfusion|September 27, 2016
Hepatitis E virus RNA in Australian blood donationsAshish C Shrestha, Robert L P Flower, Clive R Seed, et al.
Vox Sanguinis|July 25, 2024
The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working PartyJean Stanley, Michael P Busch, Christian Erikstrup, et al.
Bone Marrow Transplantation|July 16, 2013
Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115V Sanchorawala, A Hoering, D C Seldin, et al.
Transfusion|September 28, 2022
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapiesJerry A Holmberg, Stephen M Henry, Thierry Burnouf, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 24, 2016
Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantationAndrew J Cowan, Zandra K Klippel, Philip A Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Blood Advances|January 4, 2018
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myelomaDamian J Green, David G Maloney, Barry E Storer, et al.
Pageof 26

Showing results (201-210 of 256) with videos related to

Sort By:
Pageof 26
Transfusion|March 4, 2011
The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plansGraham Simmons, Simone A Glynn, Jerry A Holmberg, et al.
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 27, 2018
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance TherapyAndrew J Cowan, Philip A Stevenson, Edward N Libby, et al.
Transfusion|September 27, 2016
Hepatitis E virus RNA in Australian blood donationsAshish C Shrestha, Robert L P Flower, Clive R Seed, et al.
Vox Sanguinis|July 25, 2024
The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working PartyJean Stanley, Michael P Busch, Christian Erikstrup, et al.
Bone Marrow Transplantation|July 16, 2013
Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115V Sanchorawala, A Hoering, D C Seldin, et al.
Transfusion|September 28, 2022
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapiesJerry A Holmberg, Stephen M Henry, Thierry Burnouf, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 24, 2016
Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantationAndrew J Cowan, Zandra K Klippel, Philip A Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Blood Advances|January 4, 2018
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myelomaDamian J Green, David G Maloney, Barry E Storer, et al.
Pageof 26